Of those that currently offer coverage only for diabetes, 19% are considering offering the drugs for weight loss as well.

By employers implementing a multi-prong approach to weight health care, including offering weight management medication coverage, it will undoubtedly have positive business outcomes in the long-term.

Most doses of Zepbound have limited availability because of "demand increase for the drug," while only the highest dose of Wegovy is available, with remaining doses in short supply for a duration "to be determined," says the FDA.

On Thursday, Cigna also raised its target for long-term average annual adjusted earnings per share growth to 10%-14% from 10%-13%.